Avior Wealth Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-747
| Closed | -$1.7K | – | 887 |
|
|
2024
Q4 | $1.7K | Sell |
747
-2
| -0.3% | -$5 | ﹤0.01% | 2142 |
|
|
2024
Q3 | $2.59K | Hold |
749
| – | – | ﹤0.01% | 1934 |
|
|
2024
Q2 | $3.8K | Sell |
749
-97
| -11% | -$492 | ﹤0.01% | 1805 |
|
|
2024
Q1 | $7.16K | Hold |
846
| – | – | ﹤0.01% | 1970 |
|
|
2023
Q4 | $3.46K | Hold |
846
| – | – | ﹤0.01% | 1243 |
|
|
2023
Q3 | $2.54K | Hold |
846
| – | – | ﹤0.01% | 1357 |
|
|
2023
Q2 | $26.1K | Hold |
846
| – | – | ﹤0.01% | 890 |
|
|
2023
Q1 | $41.9K | Buy |
+846
| New | +$41.9K | ﹤0.01% | 816 |
|